Results 161 to 170 of about 189,217 (189)

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Quantitative analysis of the diffusion characteristics of China's long-term care insurance policy based on the PMC index model. [PDF]

Front Public Health
Duan P, Wang J, Zhang R, Jia H, Sun H, Li Y.   +5 more
europepmc   +1 more source

Low‐intervention clinical trials in Spain: Do they progress?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza, Mayro J. Cortés Pestana, Kristopher Amaro, Rosa M. Antonijoan, Caridad Pontes   +4 more
wiley   +1 more source

Improving healthcare efficiency through long-term care insurance (LTCI): a super-SBM and DID analysis of 291 Chinese cities. [PDF]

Front Public Health
Jin T, Halili A.
europepmc   +1 more source

Did the COVID-19 pandemic increase the long-term care insurance certification rate in Japan? An interrupted time-series analysis. [PDF]

Geriatr Gerontol Int
Seino S, Hata T, Mori H, Shinkai S, Fujiwara Y, Kobayashi E.   +5 more
europepmc   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Long-term care insurance in China: Current challenges and recommendations. [PDF]

J Glob Health
Chen S, Li L, Jiao L, Gong S, Wang Z, Liu H, Geldsetzer P, Yang J, Barnighausen T, Wang C.   +9 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Shaping Long-term Care Insurance Intentions Among Chinese Adults Aged 50-70: Role of Information Interventions in Health Risks. [PDF]

Innov Aging
Liu J, Hao J, Maitland E, Nicholas S, Wang J, Leng A.   +5 more
europepmc   +1 more source